Answers are grounded in this paper and cite their sources.
Examines keratinocyte responses to excimer light in human skin, suggesting insights for skin disease treatments.
Targeted phototherapy using 308-nm excimer light (EL-308) is widely employed to treat localized skin diseases, such as psoriasis and vitiligo. Although its immunomodulatory effects are well established, tissue-level epidermal responses to EL-308 in human skin explants have not been fully characterized in a controlled ex vivo setting. Therefore, the present study examined dose- and time-dependent changes in keratinocyte proliferation, apoptosis, and differentiation markers in a human organ-cultured skin model without systemic immune inputs (i.e., without circulation-dependent immune-cell recruitment). Human organ-cultured skin samples were irradiated with EL-308 at 300, 400, or 600 mJ/cm2 and analyzed on days 2, 5, and 7 using immunohistochemical markers, including Ki-67, TUNEL, CK10, CK16, involucrin, and integrin β1. RNA sequencing was performed 24 h after irradiation with 600 mJ/cm2, followed by KEGG and GO enrichment analyses. EL-308 exposure was associated with dose- and time-dependent changes in Ki-67 and TUNEL labeling and with altered expression of differentiation-related markers (integrin β1, CK16, CK10, and involucrin). Transcriptomic analyses revealed enrichment of metabolic and epidermis-related gene sets, including keratinization and epidermal development terms, consistent with a tissue-level response to UVB exposure. These findings provide descriptive data on epidermal marker dynamics and associated transcriptional programs after EL-308 irradiation in human organ-cultured skin and may inform future studies designed to evaluate early damage markers and functional outcomes.
No takes yet. Share an insight, caveat, or question.
Okazaki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: